CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale EVP, Research & CSO sold 3,510 shares at $38.00 ($133,380)
- 4 Exercise or conversion EVP, Research & CSO acquired 3,700 shares (option exercise)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $31.71 ($120,638)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $31.90 ($398,694)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at an average $29.99 ($114,098)
- 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $42.92 ($238,632)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $32.89 ($411,159)
- 4 Open-market sale Chief Business Officer sold 6,943 shares at $39.15 ($271,796)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $50.95 ($636,855)
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $51.08 ($403,563)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $50.90 ($636,222)
- 4 Open-market sale Chief Business Officer sold 11,110 shares at $47.65 ($529,404)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $47.99 ($379,090)
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $48.85 ($385,876)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $49.53 ($619,118)
- 4 Open-market sale CFO sold 30,000 shares at $50.06 ($1,501,731)
Page 21 of 25 · 491 filings